Celsion Corporation, an integrated development clinical stage oncology drug company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies for the treatment of cancer. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trial for treating primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Show more...
FAQ
Imunon 今天的股價是多少?▼
CBO0.STU 目前價格為 €1.86 EUR,過去 24 小時上漲了 +1.09%。在圖表上更密切關注 Imunon 股價表現。
Imunon 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Imunon 的股票以代號 CBO0.STU 進行交易。
Imunon 下一次財報日期是什麼時候?▼
Imunon 將於 August 06, 2026 公布下一次財報。
Imunon 上一季度的財報如何?▼
CBO0.STU 上一季度的財報為每股 -0.72 EUR,預估為 -1.04 EUR,帶來 +30.86% 的驚喜。下一季度的預估財報為每股 不適用 EUR。
Imunon 有多少名員工?▼
截至 May 25, 2026,公司共有 27 名員工。
Imunon 位於哪個產業?▼
Imunon從事於Manufacturing產業。
Imunon 何時完成拆股?▼
Imunon 上次拆股發生於 August 07, 2025,比例為 1.15:1。
Imunon 的總部在哪裡?▼
Imunon 的總部位於 美國 的 Lawrence Township。